<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231058</url>
  </required_header>
  <id_info>
    <org_study_id>USL area vasta NordOvest</org_study_id>
    <nct_id>NCT04231058</nct_id>
  </id_info>
  <brief_title>Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <acronym>COPD</acronym>
  <official_title>The Effects of Acupuncture and Acu-TENS in the Non-pharmacological Treatment of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda USL Toscana Nord Ovest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Auxilium Vitae Volterra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azienda USL Toscana Nord Ovest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dyspnoea is one of the most important determinants of quality of life and often limits the
      activities of daily life, in subjects suffering from moderate-to-severe chronic obstructive
      pulmonary disease (COPD). Pharmachological treatment of dyspnoea is affected by several side
      effects and, in long-lasting treatments, a reduction of clinical efficacy may occur. Previous
      studies showed a reduction of perceived dyspnoea after trials of acupuncture or
      Transcutaneous Electrical Nerve Stimulation over acupoints (Acu-TENS).

      In this study will be investigated the effect of acupuncture or Acu-TENS on lung function and
      dyspnoea in patients with moderate-to-severe COPD (Cronic Obstructive Pulmonary Disease).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the study is to verify the effectiveness of treatment with Acupuncture or with
      Acu-TENS to reduce the subjective and objective perception of dyspnoea in patients suffering
      from moderate-to severe COPD. Secondary aims are to investigate the effects of the above
      treatments on quality of life, exercise capacity, pulmonary lung function.

      Forty five consecutive patients, admitted to Auxilium Vitae Rehabilitation Centre for
      intensive pulmonary rehabilitation (PR) programme, suffering from moderate-to-severe COPD,
      will be enrolled. Subjects will be randomly assigned to three groups with different
      treatments (n=15 group 1: experimental subjects - PR+Acupuncture, n=15 group 2: experimental
      subjects - PR+Acu-TENS and n=15 group3: control subjects - PR only) by sequential block
      randomization.

      An intensive inpatient PR programme will be applied to all participants. The programme will
      include the optimisation of drug therapy and daily sessions of:

        1. Supervised incremental exercises on a treadmill, a cycle,and an arm ergometer according
           to the protocol suggested by Maltais et al. until the achievement of 30 min of
           continuous exercise at an intensity that elicited dyspnoea at level 5 on a modified Borg
           scale starting from a workload corresponding to 50% of maximal workload achieved during
           an initial incremental test;

        2. Abdominal, upper- and lower-limb muscle activities involving lifting of progressively
           increasing light weight and shoulder and full-arm circling;

        3. Education;

        4. Nutritional programs and psychosocial counselling, when appropriate. A multidisciplinary
           team of chest physicians, nurses, physical therapists, a dietician, and a psychologist
           offered care.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Baseline dyspnea evaluated with Baseline Dyspnea Index (BDI)</measure>
    <time_frame>baseline</time_frame>
    <description>Assessment of the perception of dyspnea with the basal dyspnea index (BDI) which measures the severity of dyspnea in a single state. The score ranges from 0 to 12. The lower the score, the worse the dyspnea severity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transitional dyspnea evaluated with Transitional Dyspnea Index (TDI)</measure>
    <time_frame>2 week and 4 week</time_frame>
    <description>Evaluation of the perception of dyspnea with a transitional dyspnea index (TDI) that measures changes in the severity of dyspnea compared to the baseline established by the Baseline Dyspnea Index (BDI). Rated from seven degrees ranging from -3 (major deterioration) to +3 (major improvement).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life: SGRQ (St. George's Respiratory questionnaire)</measure>
    <time_frame>baseline ,2 week and 4 week</time_frame>
    <description>Change in quality of life evaluated with the SGRQ (St. George's Respiratory questionnaire)that is an instrument designed to measure impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Composed of 50 items .Total score ranging - 9 to + 9. The lower the score, the more deterioration in severichange inty of dyspnea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in functional capacity with the six-minute walk test (6mwt)</measure>
    <time_frame>baseline , 2 and 4 week</time_frame>
    <description>The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in respiratory volumes</measure>
    <time_frame>baseline, 2 and 4 week</time_frame>
    <description>Variation of Forced expiratory volume in 1 second (FEV1), Forced vital capacity (FVC), Vital capacity (VC) and Forced expiratory volume in the 1st second (FEV1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in respiratory muscle function</measure>
    <time_frame>baseline, 2 and 4 week</time_frame>
    <description>Variation of MIP (Maximal Inspiratory Pressure) and MEP (Maximal Expirator Pressure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lung diffusion capacity</measure>
    <time_frame>baseline, 2 and 4 week</time_frame>
    <description>Variation of Diffusing capacity (DLCO)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of the disease</measure>
    <time_frame>baseline, 2 and 4 week</time_frame>
    <description>Impact of the disease will be evaluated by the CAT (Chronic Obstructive Pulmonary Disease Assessment Test).
CAT are simple questionnaires that may be used to determine the severity of symptoms. Scores on CAT range from 0-40 with the higher the score, the more severe the disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's dissociative experience related to the stress measured with the Dissociative Experiences Scale (DES)</measure>
    <time_frame>baseline, 2 and 4 week</time_frame>
    <description>The Dissociative Experiences Scale (DES) is a psychological self-assessment questionnaire that measures dissociative symptoms. It contains twenty eight questions in which a percentage answer from 0 to 100% is given for each.
The overall result, in percentage from 0 to 100, is obtained by dividing the sum of the percentage of each individual question by 28 which is the total number of questions.
Patients with scores over 30 will be diagnosed with having dissociative identity disorder</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 experimental subjects treated with Acupuncture and Pulmonary Rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcutaneous Electrical Nerve Stimulation (TENS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 experimental subjects treated withTENS and Pulmonary Rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rehabilitation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>15 experimental subjects treated with Pulmonary Rehabilitation only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>acupuncture and pulmonary rehabilitation</intervention_name>
    <description>two treatments with acupuncture per week for 4 weeks each , lasting 20 minutes</description>
    <arm_group_label>acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TENS and pulmonary rehabilitation</intervention_name>
    <description>two treatments with TENS per week for 4 weeks each , lasting 45 minutes</description>
    <arm_group_label>Transcutaneous Electrical Nerve Stimulation (TENS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of moderate-to-severe COPD (ATS-ERS definition)

          -  Patients who have not participated in a respiratory rehabilitation program within the
             previous 3 months

          -  Patients admitted to the multi-specialist Rehabilitation Center Auxilium Vitae
             Volterra SPA for inpatient PR programme

          -  stable clinical conditions and absence of clinical deterioration, with stable dyspnea,
             cough and sputum; stability of blood gas values in the absence of signs of edema or
             heart failure

          -  Expression of informed consent valid for participation in the study

          -  Good collaboration in the activities foreseen by the study

        Exclusion Criteria:

          -  Insufficient degree of cooperation

          -  Inability to walk independently

          -  Denial of informed consent to participate in the study

          -  patients with known serious cardiovascular diseases (unstable angina, advanced chronic
             heart failure, aortic aneurisms, etc.) contraindicating the inclusion in exercise
             training programmes; chronic neurological or musculoskeletal diseases impairing their
             ability to comply with study procedures; severe renal failure or end-stage dialysis,
             advanced cancer, epilepsy and other clinical conditions interfering with the
             procedures and the safety of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erika mannelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>USL Toscana Nordovest</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Tani, MD</last_name>
    <phone>+39058891682</phone>
    <email>alessandro.tani@alice.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guido vagheggini, MD</last_name>
    <phone>+393473665513</phone>
    <email>guidovagheggini@libero.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Auxilium Vitae Volterra</name>
      <address>
        <city>Volterra</city>
        <state>Toscana</state>
        <zip>56048</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Mazzoleni S, Montagnani G, Vagheggini G, Buono L, Moretti F, Dario P, Ambrosino N. Interactive videogame as rehabilitation tool of patients with chronic respiratory diseases: preliminary results of a feasibility study. Respir Med. 2014 Oct;108(10):1516-24. doi: 10.1016/j.rmed.2014.07.004. Epub 2014 Jul 16.</citation>
    <PMID>25087837</PMID>
  </reference>
  <reference>
    <citation>Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agust√≠ AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.</citation>
    <PMID>26028628</PMID>
  </reference>
  <results_reference>
    <citation>Ngai SP, Spencer LM, Jones AY, Alison JA. Acu-TENS Reduces Breathlessness during Exercise in People with Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med. 2017;2017:3649257. doi: 10.1155/2017/3649257. Epub 2017 Feb 20.</citation>
    <PMID>28303156</PMID>
  </results_reference>
  <results_reference>
    <citation>Ngai SP, Jones AY, Hui-Chan CW, Ko FW, Hui DS. Effect of 4 weeks of Acu-TENS on functional capacity and beta-endorphin level in subjects with chronic obstructive pulmonary disease: a randomized controlled trial. Respir Physiol Neurobiol. 2010 Aug 31;173(1):29-36. doi: 10.1016/j.resp.2010.06.005. Epub 2010 Jun 16.</citation>
    <PMID>20601209</PMID>
  </results_reference>
  <results_reference>
    <citation>Lau KS, Jones AY. A single session of Acu-TENS increases FEV1 and reduces dyspnoea in patients with chronic obstructive pulmonary disease: a randomised, placebo-controlled trial. Aust J Physiother. 2008;54(3):179-84.</citation>
    <PMID>18721121</PMID>
  </results_reference>
  <results_reference>
    <citation>Yu M, Gao L, Kong Y, Yan Y, Shi Q, Si D, Bao H, Sun H, Li L, Li Y. Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol. Medicine (Baltimore). 2019 Sep;98(37):e17112. doi: 10.1097/MD.0000000000017112.</citation>
    <PMID>31517846</PMID>
  </results_reference>
  <results_reference>
    <citation>Suzuki M, Muro S, Ando Y, Omori T, Shiota T, Endo K, Sato S, Aihara K, Matsumoto M, Suzuki S, Itotani R, Ishitoko M, Hara Y, Takemura M, Ueda T, Kagioka H, Hirabayashi M, Fukui M, Mishima M. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med. 2012 Jun 11;172(11):878-86.</citation>
    <PMID>22905352</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>December 16, 2019</study_first_submitted>
  <study_first_submitted_qc>January 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda USL Toscana Nord Ovest</investigator_affiliation>
    <investigator_full_name>Alessandro Tani</investigator_full_name>
    <investigator_title>Doctor in Department of Anesthesia and Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>acupuncture</keyword>
  <keyword>Transcutaneous Electrical Nerve Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

